Blog
FDA May Consider Ban of High-Dose Zocor Because of Side Effects
The U.S. Food & Drug Administration (FDA) is currently reviewing data on the side effects of the anti-cholesterol medication Zocor (simvistatin) and will consider “withdrawal of high-dose simvastatin from the market,” according to comments from the FDA scientists published in the latest issue of the New England Journal of Medicine. On March 19, 2010,…
Bisphosphonates Generate Ambiguous Results Regarding Esophageal Cancer
In an all too familiar situation, the U.S. Food and Drug Administration (FDA) has found itself re-examining safety data regarding the use of bisphosphonate medications. This turn of events comes in the wake of numerous conflicting reports that provide the public with ambiguous results regarding oral bisphosphonates and the risk of esophageal cancer. Bisphosphonates…
Evidence Lends Weight to Long-Suspected Link Between Dietary Supplements and Liver Injury
Dietary supplements constitute a luxury in many affluent societies. Their properties contain a variety of ingredients, ranging from vitamins and anti-oxidants to fiber, proteins, amino acids, and herbal constituents. Due to an increased awareness of health in recent years, consumers are turning to dietary supplements to optimize their nutritional status. Unfortunately, the use of…
Fluvoxamine Birth Defects Lawyer & Lawsuit
The SSRI antidepressant Fluvoxamine (Faverin and Symbyax) has been linked to a number of extremely serious birth defects including Persistent Pulmonary Hypertension of the Newborn (PPHN), heart, lung, abdominal and cranial defects. Fluvoxamine Lawsuit Update: On July 4, 2011, a study published in the Archives of General Psychiatry announced that children born to mothers…
Increase In Metal-On-Metal Hip Replacement Failure Rates Causes Concern
Recent evidence suggests that the use of metal-on-metal hip replacement systems may coincide with a significant increase in adverse soft-tissue reactions. More specifically, the surgical application of DePuy Articular Surface Replacement (ASR) systems has recently become the subject of mounting criticism in the healthcare community. Both the ASR resurfacing system and the ASR total…
Actos May Be Responsible For an Increased Risk of Urinary Bladder Cancer
In a recent turn of events, Takeda Pharmaceuticals Europe Ltd. has informed the public of important safety information concerning recent allegations against their most profitable medication. Actos (pioglitazone), is an orally administered medication intended to assist in the treatment of type 2 diabetes. Despite demonstrating a significant ability to control insulin levels, recent evidence…
Public Citizen Demands Transvaginal Mesh Recall
Public Citizen is a nonprofit organization dedicated to serving as the people’s voice in the nation’s capitol. Since 1971, they have actively championed citizen interest above government affairs. They are known for successfully challenging the corrupt practices of the pharmaceutical, nuclear and automobile industries. However, Public Citizen has recently issued a press release acknowledging…
Sexual Abuse Lawsuits Brought Before The California Supreme Court to Increase Institutional Liability
Several lawmakers have expressed their discontent regarding current statutes of limitations in sexual assault cases. As a result, those seeking legal reform have begun to scrutinize the current limits of institutional liability in California. Subsequently, the California Supreme Court is currently in the process of reviewing two cases that have the potential to extend…